{"created_at":"Sun Jan 05 22:50:26 +0000 2014","id":419964133602119680,"id_str":"419964133602119680","text":"RT @AndyBiotech: $NVS Novartis highlights research on CTL019 CAR-T: 86% CR in pediatric ALL; ~20% CR in CLL -&gt; http:\/\/t.co\/3uIGl5mEav #ASH13","source":"\u003ca href=\"http:\/\/twitter.com\/download\/iphone\" rel=\"nofollow\"\u003eTwitter for iPhone\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":75029389,"id_str":"75029389","name":"BioTraderST","screen_name":"Belgadriand","location":"","url":null,"description":null,"protected":false,"followers_count":19,"friends_count":84,"listed_count":0,"created_at":"Thu Sep 17 14:49:34 +0000 2009","favourites_count":7,"utc_offset":-32400,"time_zone":"Alaska","geo_enabled":false,"verified":false,"statuses_count":2422,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/3124958655\/8cafdf78b932b3fc09d3e8781d6e8422_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/3124958655\/8cafdf78b932b3fc09d3e8781d6e8422_normal.jpeg","profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Sat Dec 07 17:27:27 +0000 2013","id":409373603939876865,"id_str":"409373603939876865","text":"$NVS Novartis highlights research on CTL019 CAR-T: 86% CR in pediatric ALL; ~20% CR in CLL -&gt; http:\/\/t.co\/3uIGl5mEav #ASH13","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":632341632,"id_str":"632341632","name":"Andy Biotech","screen_name":"AndyBiotech","location":"","url":null,"description":"#Biotech #Medtech #Pharma Investor | Recovering Scientist | #RareDiseases Advocate | Avid Reader | Sports Fan","protected":false,"followers_count":5077,"friends_count":265,"listed_count":127,"created_at":"Tue Jul 10 19:50:09 +0000 2012","favourites_count":1567,"utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"verified":false,"statuses_count":8665,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C6E2EE","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme2\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme2\/bg.gif","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000074240482\/d961ebeb9f4fe6b084a68663b9a36738_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000074240482\/d961ebeb9f4fe6b084a68663b9a36738_normal.png","profile_link_color":"1F98C7","profile_sidebar_border_color":"C6E2EE","profile_sidebar_fill_color":"DAECF4","profile_text_color":"663B12","profile_use_background_image":true,"default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":11,"favorite_count":5,"entities":{"hashtags":[{"text":"ASH13","indices":[120,126]}],"symbols":[{"text":"NVS","indices":[0,4]}],"urls":[{"url":"http:\/\/t.co\/3uIGl5mEav","expanded_url":"http:\/\/www.novartis.com\/newsroom\/media-releases\/en\/2013\/1748415.shtml","display_url":"novartis.com\/newsroom\/media\u2026","indices":[97,119]}],"user_mentions":[]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"ASH13","indices":[137,143]}],"symbols":[{"text":"NVS","indices":[17,21]}],"urls":[{"url":"http:\/\/t.co\/3uIGl5mEav","expanded_url":"http:\/\/www.novartis.com\/newsroom\/media-releases\/en\/2013\/1748415.shtml","display_url":"novartis.com\/newsroom\/media\u2026","indices":[114,136]}],"user_mentions":[{"screen_name":"AndyBiotech","name":"Andy Biotech","id":632341632,"id_str":"632341632","indices":[3,15]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
